CANSF (Willow Biosciences) Total Stockholders Equity : $-0.48 Mil (As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Willow Biosciences Total Stockholders Equity?

Willow Biosciences's Total Stockholders Equity for the quarter that ended in Mar. 2025 was $-0.48 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Willow Biosciences's Book Value per Share for the quarter that ended in Mar. 2025 was $-0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Willow Biosciences's Debt-to-Equity for the quarter that ended in Mar. 2025 was -1.07.

Willow Biosciences Total Stockholders Equity Historical Data

The historical data trend for Willow Biosciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Willow Biosciences Total Stockholders Equity Chart

Willow Biosciences Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

-0.44

23.19

12.05

2.56

-0.35

Willow Biosciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															1.14	-0.04	0.14	-0.35	-0.48

Willow Biosciences (OTCPK:CANSF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Willow Biosciences's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-0.481	-	0)	/	144.847
	=	-0.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Willow Biosciences's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.013	+	0.504)	/	-0.481
	=	-1.07

Willow Biosciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Willow Biosciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Willow Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (OTCPK:CANSF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

45CN:Germany WLLW:Canada

Address

202, 1201 5th Street SW, Calgary, AB, CAN, T2R 0Y6

Website

https://www.willowbio.com

Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. It has a geographic presence in Canada and the United states, in which it generates the majority of its revenue from the United states.